 | • レポートコード：MRC2012B1206 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、製薬資産パフォーマンス管理（APM）の世界市場を広く調査・分析し、今後の市場展望をまとめております。製薬資産パフォーマンス管理（APM）の種類別市場規模（資産保全管理、資産信頼性管理、その他）、用途別市場規模（大企業、中小企業）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GE (US)、Bentley Systems (US)、Rockwell Software (US)、SAP (Germany)、AVEVA Group plc (UK)、Nexus Global (US)、AspenTech (US)、 ・地域別グローバル市場分析 2015年-2020年 ・製薬資産パフォーマンス管理（APM）の北米市場（アメリカ、カナダ、メキシコ） ・製薬資産パフォーマンス管理（APM）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・製薬資産パフォーマンス管理（APM）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・製薬資産パフォーマンス管理（APM）の南米市場（ブラジル、アルゼンチン） ・製薬資産パフォーマンス管理（APM）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：資産保全管理、資産信頼性管理、その他 ・用途別分析：大企業、中小企業 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Pharmaceutical Asset Performance Management (APM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Pharmaceutical Asset Performance Management (APM) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 129.3 million by 2025, from USD 106.1 million in 2019.
Market segmentation
Pharmaceutical Asset Performance Management (APM) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pharmaceutical Asset Performance Management (APM) market has been segmented into:
Asset Integrity Management
Asset Reliability Management
Other
By Application, Pharmaceutical Asset Performance Management (APM) has been segmented into:
Large Enterprises
SMEs
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmaceutical Asset Performance Management (APM) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmaceutical Asset Performance Management (APM) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmaceutical Asset Performance Management (APM) market.
The report offers in-depth assessment of the growth and other aspects of the Pharmaceutical Asset Performance Management (APM) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pharmaceutical Asset Performance Management (APM) Market Share Analysis
Pharmaceutical Asset Performance Management (APM) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmaceutical Asset Performance Management (APM) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmaceutical Asset Performance Management (APM) sales, revenue and market share for each player covered in this report.
The major players covered in Pharmaceutical Asset Performance Management (APM) are:
GE (US)
Bentley Systems (US)
Rockwell Software (US)
SAP (Germany)
AVEVA Group plc (UK)
Nexus Global (US)
AspenTech (US)
Among other players domestic and global, Pharmaceutical Asset Performance Management (APM) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Pharmaceutical Asset Performance Management (APM) Market Overview
1.1 Product Overview and Scope of Pharmaceutical Asset Performance Management (APM)
1.2 Classification of Pharmaceutical Asset Performance Management (APM) by Type
1.2.1 Global Pharmaceutical Asset Performance Management (APM) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type in 2019
1.2.3 Asset Integrity Management
1.2.4 Asset Reliability Management
1.2.5 Other
1.3 Global Pharmaceutical Asset Performance Management (APM) Market by Application
1.3.1 Overview: Global Pharmaceutical Asset Performance Management (APM) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Large Enterprises
1.3.3 SMEs
1.4 Global Pharmaceutical Asset Performance Management (APM) Market by Regions
1.4.1 Global Pharmaceutical Asset Performance Management (APM) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pharmaceutical Asset Performance Management (APM) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pharmaceutical Asset Performance Management (APM) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmaceutical Asset Performance Management (APM) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmaceutical Asset Performance Management (APM) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pharmaceutical Asset Performance Management (APM) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmaceutical Asset Performance Management (APM) Status and Prospect (2015-2025)
2 Company Profiles
2.1 GE (US)
2.1.1 GE (US) Details
2.1.2 GE (US) Major Business
2.1.3 GE (US) SWOT Analysis
2.1.4 GE (US) Product and Services
2.1.5 GE (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bentley Systems (US)
2.2.1 Bentley Systems (US) Details
2.2.2 Bentley Systems (US) Major Business
2.2.3 Bentley Systems (US) SWOT Analysis
2.2.4 Bentley Systems (US) Product and Services
2.2.5 Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Rockwell Software (US)
2.3.1 Rockwell Software (US) Details
2.3.2 Rockwell Software (US) Major Business
2.3.3 Rockwell Software (US) SWOT Analysis
2.3.4 Rockwell Software (US) Product and Services
2.3.5 Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.4 SAP (Germany)
2.4.1 SAP (Germany) Details
2.4.2 SAP (Germany) Major Business
2.4.3 SAP (Germany) SWOT Analysis
2.4.4 SAP (Germany) Product and Services
2.4.5 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.5 AVEVA Group plc (UK)
2.5.1 AVEVA Group plc (UK) Details
2.5.2 AVEVA Group plc (UK) Major Business
2.5.3 AVEVA Group plc (UK) SWOT Analysis
2.5.4 AVEVA Group plc (UK) Product and Services
2.5.5 AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nexus Global (US)
2.6.1 Nexus Global (US) Details
2.6.2 Nexus Global (US) Major Business
2.6.3 Nexus Global (US) Product and Services
2.6.4 Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
2.7 AspenTech (US)
2.7.1 AspenTech (US) Details
2.7.2 AspenTech (US) Major Business
2.7.3 AspenTech (US) Product and Services
2.7.4 AspenTech (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmaceutical Asset Performance Management (APM) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmaceutical Asset Performance Management (APM) Players Market Share
3.2.2 Top 10 Pharmaceutical Asset Performance Management (APM) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pharmaceutical Asset Performance Management (APM) Revenue and Market Share by Regions
4.2 North America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
4.3 Europe Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
4.5 South America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
5 North America Pharmaceutical Asset Performance Management (APM) Revenue by Countries
5.1 North America Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
5.2 USA Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
5.3 Canada Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
5.4 Mexico Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
6 Europe Pharmaceutical Asset Performance Management (APM) Revenue by Countries
6.1 Europe Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
6.2 Germany Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
6.3 UK Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
6.4 France Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
6.5 Russia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
6.6 Italy Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue by Countries
7.1 Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
7.2 China Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
7.3 Japan Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
7.4 Korea Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
7.5 India Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
8 South America Pharmaceutical Asset Performance Management (APM) Revenue by Countries
8.1 South America Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
8.2 Brazil Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
8.3 Argentina Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pharmaceutical Asset Performance Management (APM) by Countries
9.1 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
9.3 UAE Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
9.4 Egypt Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
9.5 South Africa Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pharmaceutical Asset Performance Management (APM) Revenue and Market Share by Type (2015-2020)
10.2 Global Pharmaceutical Asset Performance Management (APM) Market Forecast by Type (2019-2024)
10.3 Asset Integrity Management Revenue Growth Rate (2015-2025)
10.4 Asset Reliability Management Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Pharmaceutical Asset Performance Management (APM) Market Segment by Application
11.1 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2015-2020)
11.2 Pharmaceutical Asset Performance Management (APM) Market Forecast by Application (2019-2024)
11.3 Large Enterprises Revenue Growth (2015-2020)
11.4 SMEs Revenue Growth (2015-2020)
12 Global Pharmaceutical Asset Performance Management (APM) Market Size Forecast (2021-2025)
12.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Forecast (2021-2025)
12.2 Global Pharmaceutical Asset Performance Management (APM) Market Forecast by Regions (2021-2025)
12.3 North America Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
12.4 Europe Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
12.6 South America Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pharmaceutical Asset Performance Management (APM) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pharmaceutical Asset Performance Management (APM) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pharmaceutical Asset Performance Management (APM) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Pharmaceutical Asset Performance Management (APM) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GE (US) Corporate Information, Location and Competitors
Table 7. GE (US) Pharmaceutical Asset Performance Management (APM) Major Business
Table 8. GE (US) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 9. GE (US) SWOT Analysis
Table 10. GE (US) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 11. GE (US) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Bentley Systems (US) Corporate Information, Location and Competitors
Table 13. Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Major Business
Table 14. Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2018-2019)
Table 15. Bentley Systems (US) SWOT Analysis
Table 16. Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 17. Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Rockwell Software (US) Corporate Information, Location and Competitors
Table 19. Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Major Business
Table 20. Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 21. Rockwell Software (US) SWOT Analysis
Table 22. Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 23. Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. SAP (Germany) Corporate Information, Location and Competitors
Table 25. SAP (Germany) Pharmaceutical Asset Performance Management (APM) Major Business
Table 26. SAP (Germany) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 27. SAP (Germany) SWOT Analysis
Table 28. SAP (Germany) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 29. SAP (Germany) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AVEVA Group plc (UK) Corporate Information, Location and Competitors
Table 31. AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Major Business
Table 32. AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 33. AVEVA Group plc (UK) SWOT Analysis
Table 34. AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 35. AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Nexus Global (US) Corporate Information, Location and Competitors
Table 37. Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Major Business
Table 38. Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 39. Nexus Global (US) SWOT Analysis
Table 40. Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 41. Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. AspenTech (US) Corporate Information, Location and Competitors
Table 43. AspenTech (US) Pharmaceutical Asset Performance Management (APM) Major Business
Table 44. AspenTech (US) Pharmaceutical Asset Performance Management (APM) Total Revenue (USD Million) (2017-2018)
Table 45. AspenTech (US) SWOT Analysis
Table 46. AspenTech (US) Pharmaceutical Asset Performance Management (APM) Product and Solutions
Table 47. AspenTech (US) Pharmaceutical Asset Performance Management (APM) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Players (2015-2020)
Table 49. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Players (2015-2020)
Table 50. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Regions (2015-2020)
Table 52. North America Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
Table 53. North America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Table 54. Europe Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Pharmaceutical Asset Performance Management (APM) Revenue by Countries (2015-2020)
Table 57. South America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Table 60. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) by Type (2015-2020)
Table 61. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Type (2015-2020)
Table 62. Global Pharmaceutical Asset Performance Management (APM) Revenue Forecast by Type (2021-2025)
Table 63. Global Pharmaceutical Asset Performance Management (APM) Revenue by Application (2015-2020)
Table 64. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Application (2015-2020)
Table 65. Global Pharmaceutical Asset Performance Management (APM) Revenue Forecast by Application (2021-2025)
Table 66. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pharmaceutical Asset Performance Management (APM) Picture
Figure 2. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type in 2019
Figure 3. Asset Integrity Management Picture
Figure 4. Asset Reliability Management Picture
Figure 5. Other Picture
Figure 6. Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application in 2019
Figure 7. Large Enterprises Picture
Figure 8. SMEs Picture
Figure 9. Global Pharmaceutical Asset Performance Management (APM) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Pharmaceutical Asset Performance Management (APM) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Pharmaceutical Asset Performance Management (APM) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Regions in 2018
Figure 23. North America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 26. South America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 28. North America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries in 2019
Figure 30. USA Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries in 2019
Figure 35. Germany Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 36. UK Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 37. France Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries in 2019
Figure 42. China Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 45. India Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 47. South America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries in 2019
Figure 49. Brazil Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2015-2020)
Figure 57. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Type (2015-2020)
Figure 58. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Type in 2019
Figure 59. Global Pharmaceutical Asset Performance Management (APM) Market Share Forecast by Type (2021-2025)
Figure 60. Global Asset Integrity Management Revenue Growth Rate (2015-2020)
Figure 61. Global Asset Reliability Management Revenue Growth Rate (2015-2020)
Figure 62. Global Other Revenue Growth Rate (2015-2020)
Figure 63. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Application (2015-2020)
Figure 64. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Application in 2019
Figure 65. Global Pharmaceutical Asset Performance Management (APM) Market Share Forecast by Application (2021-2025)
Figure 66. Global Large Enterprises Revenue Growth Rate (2015-2020)
Figure 67. Global SMEs Revenue Growth Rate (2015-2020)
Figure 68. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
Figure 72. Europe Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
Figure 74. South America Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
製品ライフサイクル・資産管理におけるIoTの世界市場（～2026年） The Internet of Things (IoT) is the network of physical devices, vehicles, home appliances, and other items embedded with electronics, software, sensors, actuators, and connectivity which enables these things to connect and exchange data, creating opportunities for more direct integration of the phy…- グリッド資産管理の世界市場（～2026年） Market Analysis and Insights: Global Grid Asset Management Market The global Grid Asset Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Grid Asset Management Scope and Market Size Grid Asset Management marke…
- 病院資産管理の世界市場（～2026年） By improving maintenance practices, helping hospitals be more compliant to industry standards, and ensuring robust sanitation and tracking methods, hospital assest management methods can increase its productivity and improve patient prospects dramatically. Global hospital asset management market is …
- ユーティリティ資産管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Utility Asset Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.3% in the forecast period of 2020 to 2025 and will expected to reach USD 3167.2 million by 2025, from USD 2479 million in 2019. The Utility Asset…
- デジタル資産管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Digital Asset Management market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…